Chuenlei Parng

Phylonix Pharmaceuticals, Inc.

$2,901,526

Attributed

$2,901,526

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $334.8K · FY2005–06

$500K$375K$250K$125K$0

'05

'06

Funding mix

By agency

NIH$2,901,526 · 7

By mechanism

R44$2,280,105 · 3

R43$621,421 · 4

Top collaborators

No co-investigators on record.

Most similar at Phylonix Pharmaceuticals, Inc.

Same institution · by research overlap

Others in their field

Top investigators on “Drug Screening /Evaluation”

Fred M Gordin · Social And Scientific Systems, Inc.$68,001,399
John C S Breitner · Johns Hopkins University$33,065,187
Philip J Disaia · University Of California Irvine$21,551,991
George R Painter · Chimerix, Inc.$19,230,662
Gregory H Reaman · National Childhood Cancer Foundation$17,052,970
Stephen J Durako · Westat, Inc.$15,048,684

Research focus

Drug Screening /EvaluationZebrafishEmbryo /Fetus Drug Adverse EffectBioassayBiological ModelsEmbryo /Fetus PharmacologyModel Design /DevelopmentPharmacokineticsTeratogensIn Situ HybridizationGene ExpressionMolecular CloningNeoplasm /Cancer PharmacologyHigh Throughput TechnologyApoptosisCisplatinCyclophosphamideAcridinesBiomedical AutomationCell DifferentiationCysteine EndopeptidasesEmbryo /Fetus Tissue /Cell CultureEmbryogenesisFlow Cytometry